Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Pharmakologie (14 Abbildungen)
Übersicht


Zum ersten Bild Abb. 4: Angiotensin-I-Rezeptor Abb. 5: Plasma-Halbwertzeit Abb. 6: Angiotensin-I-Rezeptorblocker - Verteilungsvolumina Aktuelles Bild - Abb. 7: Telmisartan - PPAR-Gamma Abb. 8: SBD - DBD Abb. 9: Normaldosierung Abb. 10: Dosierung - Alter - Geschlecht Zum letzten Bild
Abbildung 7: Telmisartan - PPAR-Gamma
PPAR-g agonists can improve insulin sensitivity, reduce triglyceride levels and decrease the risk for atherosclerosis. This study examined the ability of different ARBs to activate PPAR-g in a cell-based transient transfection assay.1 This assay eliminates interference from endogenous nuclear receptors. In the results shown here, each ARB was applied at 10 mmol/L. Telmisartan was the only ARB to show strong (27-fold) activation, although irbesartan showed a slight activation (two- to three-fold). By comparison, full PPAR-g agonists show ~140-fold activation in this assay.1 Telmisartan was also the only ARB that activated PPAR-g when tested at lower concentrations that can be achieved physiologically (1–5 mmol/L).1 Telmisartan therefore acts as a partial agonist of PPAR-g. 1. Benson SC, Pershadsingh HA, Ho CI et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARg-modulating activity. Hypertension 2004; 43: 993–1002.
 
Telmisartan - PPAR-Gamma
Vorheriges Bild Nächstes Bild   


Abbildung 7: Telmisartan - PPAR-Gamma
PPAR-g agonists can improve insulin sensitivity, reduce triglyceride levels and decrease the risk for atherosclerosis. This study examined the ability of different ARBs to activate PPAR-g in a cell-based transient transfection assay.1 This assay eliminates interference from endogenous nuclear receptors. In the results shown here, each ARB was applied at 10 mmol/L. Telmisartan was the only ARB to show strong (27-fold) activation, although irbesartan showed a slight activation (two- to three-fold). By comparison, full PPAR-g agonists show ~140-fold activation in this assay.1 Telmisartan was also the only ARB that activated PPAR-g when tested at lower concentrations that can be achieved physiologically (1–5 mmol/L).1 Telmisartan therefore acts as a partial agonist of PPAR-g. 1. Benson SC, Pershadsingh HA, Ho CI et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARg-modulating activity. Hypertension 2004; 43: 993–1002.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung